Zhulai G A, Oleinik E K, Ostrovskii K A, Oleinik V M, Kravchenko P N, Churov A V
Eksp Klin Gastroenterol. 2014(9):21-5.
Assessment of changes in lymphocyte number and some indicators of the immune suppression (frequency of regulatory T cells (Treg), the level of expression of CTLA-4 (cytolytic T lymphocyte-associated antigen 4) and interleukin (IL)-10) in patients with acute pancreatitis (AP).
Peripheral blood samples of 21 patients with AP (including 11 patients with pancreatic necrosis (PN)) were studied for analysis of lymphocyte subsets and 11 blood samples of healthy donors were estimated as control. Evaluation of the expression of molecules of lymphocytes was carried out by flow cytometry.
It was found that percentage of CD3+ T cells and their subpopulation of CD4+ T-helper cells in patients with AP were decreased as compared to the control group. Substantial changes were observed in patients with PN: together with decrease in the number of T cells, CD19+ B cells and CD4+ CD25+ activated T-helper cells were also reduced, and the percentage of CD8+ T cells was higher. The immunoregulatory index (CD4+/CD8+) was lower in the group of patients, than in control group. The frequency of Treg cells (CD4+ CD25hi and CD4+ CD25+ CD127lo) was higher in patients with AP than in the control. The expression level of the inhibitory molecule CTLA-4 in the subset of CD4+ CD25hi Treg cells in patients with AP was also increased. Moreover, it was found that the expression level of anti-inflammatory cytokine IL-10 was higher in T-helper cells from patients with AP.
Changes in cellular immunity (especially patients with PN) werefound in patients wish AP. These changes may indicate the possible development of secondary immunodeficiency. This is probably related to the generation of immune suppression, since the values of the investigated parameters (frequency of Treg cells, the expression of CTLA-4 and IL-10) in patients with AP were higher than in controls.
评估急性胰腺炎(AP)患者淋巴细胞数量变化以及免疫抑制的一些指标(调节性T细胞(Treg)频率、细胞毒性T淋巴细胞相关抗原4(CTLA-4)表达水平和白细胞介素(IL)-10)。
研究21例AP患者(包括11例胰腺坏死(PN)患者)的外周血样本以分析淋巴细胞亚群,并将11例健康供者的血样作为对照进行评估。通过流式细胞术对淋巴细胞分子表达进行评估。
发现与对照组相比,AP患者中CD3⁺ T细胞及其CD4⁺辅助性T细胞亚群的百分比降低。PN患者出现显著变化:T细胞数量减少的同时,CD19⁺ B细胞和CD4⁺ CD25⁺活化辅助性T细胞数量也减少,且CD8⁺ T细胞百分比更高。患者组的免疫调节指数(CD4⁺/CD8⁺)低于对照组。AP患者中Treg细胞(CD4⁺ CD25hi和CD4⁺ CD25⁺ CD127lo)频率高于对照组。AP患者CD4⁺ CD25hi Treg细胞亚群中抑制性分子CTLA-4的表达水平也升高。此外,发现AP患者辅助性T细胞中抗炎细胞因子IL-10的表达水平更高。
AP患者存在细胞免疫变化(尤其是PN患者)。这些变化可能表明继发性免疫缺陷的可能发展。这可能与免疫抑制的产生有关,因为AP患者中所研究参数(Treg细胞频率、CTLA-4和IL-10的表达)的值高于对照组。